Subscribe to our Newsletters !!


    Aerogen – bringing a lower risk of transmission of patient generated infectious aerosol for healthcare professionals in acute care settings compared to traditional nebulisers

    India has 18% of the global population and an increasing burden of chronic respiratory diseases1. The technique of nebulisation is commonly utilised in the treatment of such diseases including asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD)2. Recent improvements in nebuliser technologies have led to the development of vibrating mesh nebulisers (VMNs) that produce

    DBT/BIRAC Supported Rapid test for COVID antibody detection: 100% Indigenous

    Delhi based Oscar Medicare Pvt. Ltd., manufacturer of various in-vitro diagnostic kits, has developed a rapid test for detection of COVID antibody using recombinant proteins of 100% Indian origin in collaboration with Dhiti Life Sciences Pvt. Ltd. (DLSPL). The product has been validated and approved by ICMR lab-National Institute of Virology-Pune. As per ICMR report,